Eiger BioPharmaceuticals, Inc. announced on March 8, 2024, Christine A. Murray notified the company of her resignation as a member of the Company?s Board of Directors, to be effective March 15, 2024. Ms. Murray?s resignation was not the result of any disagreement or dispute with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | -12.17% | +11.72% | -60.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.36% | 3.95M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals, Inc. Announces Christine A. Murray Notifies Resignation as Member of Board of Directors, Effective March 15, 2024